← Back to headlines
Bristol Myers Squibb Stock Jumps on Reported Merger Talks with AstraZeneca
Bristol Myers Squibb's stock experienced a significant rise following reports of potential merger discussions with AstraZeneca.
3 Aug, 13:27 — 3 Aug, 13:27
Sources
Showing 1 of 1 sources